Tag Archives: Treatment

FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults

FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults Print this page London, UK, 26 July 2019: Shield Therapeutics plc (LSE: STX), a commercial stage, pharmaceutical company with a focus on addressing iron deficiency, announces that the U.S. Food and Drug Administration (FDA) has approved its lead product Accrufer® (Feraccru® in… Read More »

Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu

FILE PHOTO: A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit Tessier/File Photo PARIS (Reuters) – French drugs and healthcare group Sanofi (SASY.PA) said on Tuesday it had signed a rights deal with Roche (ROG.S) for the ‘Tamiflu’ product in the United States. The deal will… Read More »

Ocular Therapeutix Announces FDA Approval of Dextenza (dexamethasone intracanalicular insert) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

Print this page BEDFORD, Mass.–(BUSINESS WIRE)–Jun. 21, 2019– Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Dextenza to include the treatment… Read More »